Amanda Pilling
Henry Ford Health System(US)Henry Ford Hospital(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Prostate Cancer Treatment and Research, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Lung Cancer Research Studies
Most-Cited Works
- → Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer(2012)1,061 cited
- → Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer(2013)602 cited
- → Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration‐resistant prostate cancer cells to enzalutamide(2019)51 cited
- → PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer(2021)29 cited
- → ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer(2018)26 cited
- → Folate Deficiency Provides Protection against Colon Carcinogenesis in DNA Polymerase β Haploinsufficient Mice(2010)25 cited
- → Folate deficiency regulates expression of DNA polymerase β in response to oxidative stress(2010)23 cited
- → Analysis of resistance mechanisms to ALK kinase inhibitors in ALK+ NSCLC patients.(2012)23 cited
- → Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations(2024)20 cited
- → IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration‐Resistant Prostate Cancer Cells via Autocrine TNF‐α Signaling(2017)17 cited